This assay is to provide C2BBe1-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
C2BBe1
Target Cell Organism
Human
Target Cell Background
The C2BBe1 (brush border expressing) cell line was cloned in 1988 from the Caco-2 cell line by limiting dilution. The clone was selected on the basis of morphological homogeneity and exclusive apical villin localization.
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
C2BBe1-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.